RAPT THERAPEUTICS, INC. (RAPT): Price and Financial Metrics
RAPT Price/Volume Stats
| Current price | $1.07 | 52-week high | $27.35 |
| Prev. close | $1.07 | 52-week low | $1.01 |
| Day low | $1.02 | Volume | 847,600 |
| Day high | $1.10 | Avg. volume | 762,172 |
| 50-day MA | $1.88 | Dividend yield | N/A |
| 200-day MA | $5.22 | Market Cap | 37.41M |
RAPT Stock Price Chart Interactive Chart >
RAPT THERAPEUTICS, INC. (RAPT) Company Bio
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.
RAPT Price Returns
| 1-mo | -40.22% |
| 3-mo | -54.08% |
| 6-mo | -74.40% |
| 1-year | -92.17% |
| 3-year | -96.76% |
| 5-year | -94.78% |
| YTD | -95.69% |
| 2023 | 25.51% |
| 2022 | -46.09% |
| 2021 | 85.97% |
| 2020 | -28.47% |
| 2019 | N/A |
Loading social stream, please wait...